Humble Grow Co. (OTCPK: DLTN.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Humble Grow Co. (OTCPK: DLTN.F) operates in the Pharmaceuticals industry within the Health Care sector.
Tweenvest scores Humble Grow Co. across four factors: quality 32/100, growth 93/100. Its strongest factor is growth.
DLTN.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $52.18M
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 200
- Next earnings
- —
About Humble Grow Co.
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. As of April 20, 2022, the company owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.
- ISIN
- CA2477541049
- Founded
- 2001
- Listed since
- Nov 6, 2017
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.